Posts Tagged ‘Case Study’


CASE STUDY: Using FieldStere for Scaffold Hopping

19 December 2010

The metabotropic glutamate receptors (mGluR) have become popular and important targets in small molecule drug discovery. In particular there is increasing interest in and clinical trials of mGluR5 antagonists in the treatment of anxiety, depression, pain, gastro-esophageal acid reflux disease (GERD), Parkinson’s disease, epilepsy, and Fragile X Syndrome (FXS). The allosteric binding site of mGluR5 [...]

Read Article


CASE STUDY: Virtual Screening with 11βHSD-1

19 December 2010

A local role for 11β-hydroxysteroid dehydrogenase type 1(11βHSD-1) in the control of visceral fat deposition has been established in the literature.  Although originally thought to predominate as an oxidase, converting cortisol to cortisone, this enzyme has been shown to act as a reductase in vivo for cortisone.  This strongly suggests that the inhibition of 11β [...]

Read Article


CASE STUDY: SAR Analysis and Lead Generation

19 December 2010

Chronic obstructive pulmonary disease (COPD) is a common, progressive disorder of increasing prevalence in industrialized countries. Several drugs have been marketed so far, and several molecular targets have been considered for therapeutic intervention. This project explored the SAR of known PDE4B inhibitors extracted from Thomson Reuters’ Integrity database and used this to derive models that [...]

Read Article


CASE STUDY: Using FieldTemplater in Library Design

16 December 2010

There is a delicate balance to be struck in library design between identifying all the chemical scaffolds that are potentially active, whilst retaining a manageable library of compounds that is tractable and cost-effective for routine screening. Field templates can be used in library design to predict activity of compounds both at therapeutic targets as well [...]

Read Article